Medicinal Products

PARACETAMOL ARROW 10 mg / ml solution for infusion box of 10 bottles of 50 ml

Generic drug of the therapeutic class: Analgesics
active ingredients: [Paracetamol, 659]
laboratory: Arrow Generic

Injection solution for IV infusion
All forms

Indication

PARACETAMOL ARROW 10 mg / ml is indicated in the short-term treatment of moderate intensity pain, especially in the postoperative period, and in short-term treatment. of fever, when the intravenous route of administration is clinically justified by the urgency of treating pain or hyperthermia and / or when other routes of administration are not possible.

Dosage PARACETAMOL ARROW 10 mg / ml solution for infusion box of 10 vials of 50 ml

PARACETAMOL ARROW 10 mg / ml is indicated in the short-term treatment of moderate intensity pain, especially in the postoperative period, and in short-term treatment. of fever, when the intravenous route of administration is clinically justified by the urgency of treating pain or hyperthermia and / or when other routes of administration are not possible.

Against indications

PARACETAMOL ARROW 10 mg / ml is contraindicated:

· In case of hypersensitivity to paracetamol or propacetamol hydrochloride (prodrug of paracetamol) or to any of the excipients,

· In cases of severe hepatocellular insufficiency.

Paracetamol Side Effects Arrow

Adverse effects were classified according to their incidence using the following classification:

Very common (≥1 / 10), frequent (≥1 / 100, <1/10), not very common (≥1 / 1, 000, <1/100), rare (≥1 / 10, 000, <1/1000), very rare (<1 / 10, 000), undefined frequency (can not be estimated based on available data)

system

Rare

Very rare

Gà © nà © ral

Discomfort

Hypersensitivity Reaction

Cardiovascular

hypotension

HÃ © hepatic

Elimination of hepatic transaminases

Platelets / blood

Thrombocytopà © nie

Leucopà © nie

Neutropà © nie

Very rare cases of hypersensitivity reactions ranging from simple skin rash or hives to anaphylactic shock have been reported and require discontinuation of treatment.

Cases of rhythm, flushing, pruritus and tachycardia have been reported.

Declaration of suspected untoward effects

The declaration of suspected adverse effects after authorization of the drug is important. It allows continuous monitoring of the benefit / risk ratio of the drug. Health professionals disclose any suspected adverse effects via the national reporting system: National Agency for Drug and Health Product Safety (ANSM) and network Regional Pharmacovigilance Centers - Website: www.ansm.sante.fr.

Popular Posts

Category Medicinal Products, Next Article